Search research articles
Contact Us
Filters
Showing results (241-250 of 371) with videos related to
Page
of 38
Sort By:
Cancers
|
November 27, 2021
PGRMC1 Promotes Progestin-Dependent Proliferation of Breast Cancer Cells by Binding Prohibitins Resulting in Activation of ERα Signaling
Yingxue Bai, Marina Ludescher, Gereon Poschmann, et al.
The Prostate
|
June 21, 2012
Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases
Tilman Todenhöfer, Jörg Hennenlotter, Benjamin Joachim Schmiedel, et al.
Breast Cancer Research and Treatment
|
June 23, 2018
Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment
Emanuel C A Bauer, Fabienne Schochter, Peter Widschwendter, et al.
Geburtshilfe Und Frauenheilkunde
|
January 14, 2022
Invasive Breast Carcinoma with Neuroendocrine Differentiation: A Single-Center Analysis of Clinical Features and Prognosis
Natalia Krawczyk, Rowena Röwer, Martin Anlauf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2010
Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial
Sabine Riethdorf, Volkmar Müller, Liling Zhang, et al.
Breast Cancer Research : BCR
|
July 15, 2020
Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression
Hannah Asperger, Nadia Stamm, Berthold Gierke, et al.
Cancers
|
August 26, 2022
Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial
Elisabeth K Trapp, Peter A Fasching, Tanja Fehm, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 23, 2016
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7)
Philipp Harter, Jalid Sehouli, Alexander Reuss, et al.
Breast Cancer Research and Treatment
|
September 23, 2010
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
Tanja Fehm, Volkmar Müller, Bahriye Aktas, et al.
Anticancer Research
|
July 5, 2018
Prediction of Non-sentinel Lymph Node Metastases After Positive Sentinel Lymph Nodes Using Nomograms
Ines Gruber, Maja Henzel, Birgitt Schönfisch, et al.
Page
of 38
Search research articles
Search
Showing results (241-250 of 371) with videos related to
Sort By:
Page
of 38
Cancers
|
November 27, 2021
PGRMC1 Promotes Progestin-Dependent Proliferation of Breast Cancer Cells by Binding Prohibitins Resulting in Activation of ERα Signaling
Yingxue Bai, Marina Ludescher, Gereon Poschmann, et al.
The Prostate
|
June 21, 2012
Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases
Tilman Todenhöfer, Jörg Hennenlotter, Benjamin Joachim Schmiedel, et al.
Breast Cancer Research and Treatment
|
June 23, 2018
Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment
Emanuel C A Bauer, Fabienne Schochter, Peter Widschwendter, et al.
Geburtshilfe Und Frauenheilkunde
|
January 14, 2022
Invasive Breast Carcinoma with Neuroendocrine Differentiation: A Single-Center Analysis of Clinical Features and Prognosis
Natalia Krawczyk, Rowena Röwer, Martin Anlauf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2010
Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial
Sabine Riethdorf, Volkmar Müller, Liling Zhang, et al.
Breast Cancer Research : BCR
|
July 15, 2020
Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression
Hannah Asperger, Nadia Stamm, Berthold Gierke, et al.
Cancers
|
August 26, 2022
Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial
Elisabeth K Trapp, Peter A Fasching, Tanja Fehm, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 23, 2016
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7)
Philipp Harter, Jalid Sehouli, Alexander Reuss, et al.
Breast Cancer Research and Treatment
|
September 23, 2010
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
Tanja Fehm, Volkmar Müller, Bahriye Aktas, et al.
Anticancer Research
|
July 5, 2018
Prediction of Non-sentinel Lymph Node Metastases After Positive Sentinel Lymph Nodes Using Nomograms
Ines Gruber, Maja Henzel, Birgitt Schönfisch, et al.
Page
of 38